Results 161 to 170 of about 10,636 (185)

The Atypical Face of Neuroleptic Malignant Syndrome: A Case Report of Ileus and Absent Rigidity. [PDF]

Cureus
Kutumbaka T, Varadan S, Sudagar Singh RB.   +2 more
europepmc   +1 more source

Incidence of Neuroleptic Malignant Syndrome During Antipsychotic Treatment in Children and Youth: A National Cohort Study. [PDF]

J Child Adolesc Psychopharmacol
Ray WA, Fuchs DC, Olfson M, Stein CM, Murray KT, Daugherty J, Cooper WO.   +6 more
europepmc   +1 more source

Long prodromal symptoms of neuroleptic malignant syndrome in patient with intellectual developmental disorder-A case report. [PDF]

Neuropsychopharmacol Rep
Sadati S, Elyasi F, Shyasi Z, Rouhanizadeh B.   +3 more
europepmc   +1 more source

Serotonin syndrome and neuroleptic malignant syndrome: A case report of intersecting symptomatology. [PDF]

Ment Health Clin
Maktabi L, Shipman D, Reinert JP.
europepmc   +1 more source

Atypical Presentation of Ziprasidone-Induced Neuroleptic Malignant Syndrome: A Case Report. [PDF]

J Investig Med High Impact Case Rep
Allonce J, Khan S, Pulford B.
europepmc   +1 more source

Successful Diagnosis of Neuroleptic Malignant Syndrome in an Unconscious Patient Using Amplitude-Integrated Electroencephalography: A Case Report. [PDF]

Cureus
Nakamura S, Iida A, Tsukahara K, Naito H.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neuroleptic Malignant Syndrome

Archives of General Psychiatry, 1987
SummarySince the initial description of neuroleptic malignant syndrome (NMS) 40 years ago, a wealth of clinical data has accumulated on the manifestations, course, treatment, and pathogenesis of this uncommon but serious and potentially lethal drug reaction.
S N, Caroff, S C, Mann, A, Lazarus
  +9 more sources

Neuroleptic malignant syndrome

Annals of Emergency Medicine, 1985
We present the case of a 35-year-old man who developed symptoms of the neuroleptic malignant syndrome (NMS) after taking prescribed, moderately high, therapeutic doses of haloperidol. When brought to the emergency department, he was comatose, hypotensive, and had rigid muscle tone and a core body temperature of 42.2 C.
M L, Martin, E J, Lucid, R W, Walker
  +11 more sources

Neuroleptic malignant syndrome

Medical Clinics of North America, 1993
Neuroleptic malignant syndrome is a rare but potentially fatal reaction associated with neuroleptic drugs. It occurs in about 0.2% of patients treated with neuroleptics. Risk factors include previous episodes, dehydration, agitation, and the rate and route of neuroleptic administration.
S N, Caroff, S C, Mann
openaire   +3 more sources